SATLANTIS Will Launch Its Second Nano-Camera Into Space in 2022

UF startup and UF Innovate | The Hub resident company SATLANTIS, a provider of high-performance payload technologies for Earth observation and remote sensing, will launch its second nano-camera into space in 2022. The plans were announced during the annual meeting held in Bilbao, Spain, by its Advisory Council, which is proud of the success achieved in the first […]

UF Based Company Develops Technology for Cheaper Tech Screens to Sell Globally

You might not think much about how your phone or TV screen works the way it does. As you can guess, there’s plenty of technology behind it–literally. One group of University of Florida graduates have built a company around that technology. It’s called Mattrix Technologies, a UF startup and UF Innovate | The Hub resident […]

The Key to Farming on Mars Might Be Breeding Parasitic Space Worms

The parasitic space worms are coming, and they’re ready to kill. No, it’s not the tagline for some Tremors in Space B-movie monster flick. Instead, it’s the result of some research recently published in the journal npj Microgravity by UF Innovate | The Hub and UF Innovate | Sid Martin Biotech alum Pheronym, an Ag-biotech pest control company. And despite how it […]

Slice Listed as a Top Startup to Follow by Welp Magazine

No one knows yet what the final effects of 2020 will be on the global economy, public health, and political structures. One thing is for sure though, additive manufacturing (3D printing) is here to stay. In the midst of the upheaval of supply chains and a realization of the importance of localized manufacturing, 3D printing has […]

Oxidien Pharmaceuticals Selected as Winner of Buzz of BIO in Early Stage Entrepreneur Category

UF Innovate | The Hub resident client Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company mitigating kidney stone disease by treating secondary hyperoxaluria, announced that it was recognized as a winner in Buzz of BIO, in the Early Stage Entrepreneur category following a nomination and extensive voter participation. Helena Cowley, CEO of Oxidien Pharmaceuticals said, “We are grateful for everyone’s […]

Oxidien Announces Publication of Clinical Results Demonstrating Significant Reduction in Urinary Oxalate

UF Innovate | The Hub resident client Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company mitigating kidney stone disease by treating secondary hyperoxaluria, announced the publication of data from a clinical study on the effectiveness of its highly potent and acid-stable Oxalate Decarboxylase (OxDC) to reduce urinary oxalate in subjects on a high oxalate diet. The study was […]